Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH CTC enumeration to guide treatment decisions in a specific metastatic breast cancer subtype
The secondary analysis of the PACE trial highlights the value of counting…
Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium
In addition, the expansive elacestrant clinical development program updates reinforce its potential as…
Menarini Group Announces New Data on ELZONRIS (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition
Data spans five abstracts including two oral presentations with important findings for…
The Volpi Rosse Menarini: The ‘Fantastic Ten’ are ready for the 2025 – 2026 Season
Italian wheelchair basketball team, sponsored by Menarini, was presented to the press…
FAIR PLAY MENARINI INTERNATIONAL AWARD, A WAVE OF EMOTIONS MARKS THE 29TH EDITION
FIESOLE, Italy, July 4, 2025 /PRNewswire/ -- A night suspended between history…
FAIR PLAY MENARINI INTERNATIONAL AWARD: THE 29TH EDITION OFFICIALLY BEGINS
FLORENCE, Italy, July 2, 2025 /PRNewswire/ -- Medals and records alone are not…
FAIR PLAY MENARINI INTERNATIONAL AWARD, LUIS FIGO JOINS THE GREAT SPORTS STARS ACKNOWLEDGED IN 2025
FLORENCE, Italy, July 1, 2025 /PRNewswire/ -- Surprises never end when it…
FAIR PLAY MENARINI INTERNATIONAL AWARD, THE 2025 EDITION BEGINS WITH THE ANNOUNCEMENT OF THIS YEAR’S AWARDEES AT CONI
ROME, June 11, 2025 /PRNewswire/ -- The sense of anticipation is increasing,…
